AstraZeneca has agreed to transfer its global rights for respiratory medicines Eklira (Aclidinium bromide) and Duaklir (Aclidinium bromide/formoterol) to Covis Pharma Group.
KEYPOINTS AstraZeneca has agreed to transfer its global rights to Eklira (Aclidinium bromide), known as Tudorza in the US, and Duaklir (Aclidinium…